Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/127,147external-prioritypatent/US4910226A/en
Application filed by Smithkline Beckman CorpfiledCriticalSmithkline Beckman Corp
Priority to FI943835ApriorityCriticalpatent/FI109028B/en
Publication of FI943835A0publicationCriticalpatent/FI943835A0/en
Publication of FI943835LpublicationCriticalpatent/FI943835L/en
Application grantedgrantedCritical
Publication of FI109028BpublicationCriticalpatent/FI109028B/en
3-Aminoalkyl-1H-indole-5-methanesulfonamide compound and pharmaceutical preparation with carotid artery narrowing action (Sumatriptan and its salts and solvates including sumatriptan succinate)
17-BETA-CARBAMOYL N-MONOSUBSTITUIDE- OR 17-BETA-ACYL-4-AZA-5-ALPHA-ANDROST-1-EN-3-ONAS AS A 5-ALPHA REDUCTASE INHIBITORS FOR THE PREPARATION OF 17-BETA-